A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a study published online Dec. 9 in Pediatric Blood & Cancer.
12, 2024 — Scientists have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...
Small lymphocytic lymphoma is another indolent B-cell lymphoma. It is very similar to chronic lymphocytic leukemia (CLL), except that the disease tends to be located in the lymph nodes. Often, more ...
Ten years after its first FDA approval, Amgen’s Blincyto continues to make inroads in treating acute lymphoblastic leukemia. Now, the drug has delivered a phase 3 win that further demonstrates ...
Hematologist-oncologists are doctors who specialize in treating blood cancers such as acute lymphoblastic leukemia (ALL). ALL is a rare, rapidly progressing cancer of the blood and bone marrow.
Chronic lymphocytic leukemia (CLL) is a type of cancer affecting the bone marrow lymphocytes. It can affect B or T cells and may be slow- or fast-growing. CLL is a common type of leukemia ...
AstraZeneca has positive data suggesting two fixed-duration combinations containing its Calquence can work in newly diagnosed chronic lymphocytic leukemia (CLL). Calquence, given alongside ...
We present a case of pro-B-cell acute lymphoblastic leukemia (ALL) with hyperleukocytosis in a 6-month-old infant, characterized by a positive KMT2A/AFF1 fusion gene with a leukocyte count of 1,755 × ...
B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading cause of cancer-related death among ...
Just days before his fourth birthday, Santiago was diagnosed with B-cell acute lymphoblastic leukemia (B-ALL), the most common cancer in children. He began chemotherapy the next day, and the ...
Leukemia can result in high blood sugar for a number of reasons, such as stress and side effects from cancer treatment. This can be managed by taking your medication as prescribed and following a ...
Jan. 17, 2020 — A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia (AML), one of the most common forms of blood cancer. The ...